Editor

8390 POSTS
0 COMMENTS

Azacitidine Plus Venclexta Superior to Chemo in Acute AML

Amongst match sufferers with acute myeloid leukemia, the mix of azacitidine plus Venclexta (venetoclax) was related to a considerably improved event-free survival...

Older Sufferers With DLBCL Could Profit From First-Line Epkinly Plus R-mini-CHOP

Amongst older sufferers with newly identified diffuse massive B-cell lymphoma (DLBCL), remedy with fixed-duration Epkinly (epcoritamab-bysp) plus dose-attenuated Rituxan (rituximab) plus cyclophosphamide,...

Black Sufferers With AML Face Decrease Survival Outcomes

Amongst sufferers with acute myeloid leukemia, Black race has been discovered to be an impartial prognostic issue for decrease survival outcomes, no...

Larger Niktimvo Dosing Possible in Power Graft-Versus-Host Illness

Amongst sufferers experiencing persistent graft-versus-host illness (cGVHD), the transition of remedy with Niktimvo (axatilimab) to a dose of 0.6 milligrams per kilogram...

KRd Improves Development in Newly Recognized Sufferers With Myeloma

Amongst sufferers who have been newly identified with a number of myeloma, Kyprolis (carfilzomib) plus Revlimid (lenalidomide) and dexamethasone (KRd) was related...

Editor

8390 POSTS
0 COMMENTS
spot_img